Medical Weight Loss for Kalamazoo, Michigan Residents

Kalamazoo, Michigan residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Kalamazoo through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Kalamazoo, Michigan by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Kalamazoo Residents Choose New Hope Weight Loss

Cost should not be a guessing game, and in Kalamazoo it is not. Our flat pricing means semaglutide from $166 a month, tirzepatide from $233 a month, and a $119 physician review, with the medication billed separately and nothing buried in fine print. People across Michigan tell us the relief of simply knowing the number ahead of time is half the reason they finally got started.

Medical weight loss for Kalamazoo is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Your zip code in Kalamazoo, Michigan does not change the medicine or the doctor, only the way you connect, since Dr. Anjmun Sharma supervises every patient remotely from Costa Mesa. We care for patients throughout downtown Kalamazoo, the university area, and the greater Kalamazoo County area. Semaglutide starts from $166 a month, or $499 for the 90-day program, and tirzepatide from $233 a month, the same pricing for every Michigan patient.

Your zip code inside Michigan does not raise or lower the price, and it does not move you down a waitlist, because the whole program runs remotely. Between Klarna, Affirm, and HSA or FSA cards, Kalamazoo patients have several ways to handle the $119 review and ongoing medication payments. New Hope Weight Loss reaches patients all across Michigan, from the Lower Peninsula to the Upper, by telehealth from our Costa Mesa, California clinic, with no local office needed.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Kalamazoo meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Kalamazoo

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Kalamazoo. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Kalamazoo address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Kalamazoo

I am searching for weight loss care near Kalamazoo. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Kalamazoo, Michigan connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Kalamazoo?

Not at all. The telehealth format covers Kalamazoo patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Kalamazoo in cold-pack packaging built to keep it cool and stable.

What are the program costs for Kalamazoo patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Kalamazoo patients face no distance surcharge.

What areas of Kalamazoo do you serve?

We serve patients from across Kalamazoo by telehealth, including downtown Kalamazoo, the university area, and the greater Kalamazoo County area.

Is my health information private as a Kalamazoo patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Kalamazoo patients get the same confidentiality as any telehealth patient.

Kalamazoo Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kalamazoo, Michigan by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.